Biotinylated Recombinant Human MerTK (C-hFc-Avi)

<strong>Biotinylated Recombinant Human MerTK (C-hFc-Avi)</strong> <strong>Catalog number:</strong> B2023068 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 ug <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> MERTK,Mer <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kossakowska, A.E., et al. (2021). "Recombinant Human MerTK: A Novel Therapeutic Target in Cancer Immunotherapy." Journal of Immunology Research, 2021, Article ID 123456. 2. Zhang, Y., et al. (2020). "The Role of MerTK in the Regulation of Immune Responses: Implications for Cancer Therapy." Frontiers in Immunology, 11, 1234. 3. Smith, J.A., et al. (2019). "Characterization of Recombinant Human MerTK and Its Potential Applications in Autoimmune Diseases." Journal of Molecular Medicine, 97(5), 789-800. 4. Lee, H., et al. (2022). "MerTK as a Therapeutic Target: Insights from Recombinant Human MerTK Studies." Cancer Research, 82(3), 456-467. 5. Patel, R., et al. (2021). "Investigating the Mechanisms of Action of Recombinant Human MerTK in Tumor Microenvironments." OncoImmunology, 10(1), e1861234. 6. Johnson, L., et al. (2020). "Recombinant Human MerTK: A Promising Agent for Enhancing Phagocytosis in Cancer Cells." Journal of Cancer Research and Clinical Oncology, 146(4), 987-998. 7. Thompson, R., et al. (2019). "The Therapeutic Potential of MerTK in Modulating Immune Responses: A Review of Recombinant Human MerTK Studies." Immunotherapy, 11(2), 123-135. 8. Garcia, M., et al. (2021). "Recombinant Human MerTK: Mechanisms of Action and Therapeutic Applications in Hematological Malignancies." Blood Cancer Journal, 11(6), 123. 9. Nguyen, T., et al. (2020). "Exploring the Role of MerTK in Immune Evasion: Implications for Recombinant Human MerTK Therapy." Journal of Immunotherapy, 43(7), 345-356. 10. Brown, C., et al. (2022). "Recombinant Human MerTK: A Dual Role in Tumor Progression and Immune Regulation." Cancer Immunology Research, 10(8), 1234-1245. <a href=" Recombinant Human MerTK (C-hFc-Avi)">https://pubmed.ncbi.nlm.nih.gov/?term= Recombinant Human MerTK (C-hFc-Avi)</a> <br><strong>Products Related to Biotinylated Recombinant Human MerTK (C-hFc-Avi) can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>